Skip to main content
Equibles
KWR logo

KWR · Quaker Chemical Corp

Track KWR — free

Use KWR with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research KWR.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$155.43 +1.61 (+1.05%) At close · Nov 13
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$2.67B
Shares
17.19M
Volume · Nov 13 138.68K Avg daily vol (3M) 147.93K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$155.43 Open$155.00 Day$152.51–155.57 52W close$114.74–180.57 Avg vol 30d148K Short int1.6M · 9.6% of shares · 10.7d Short vol76% Last earningsOct 30, 2026 DataJan 2020–Nov 2026 Filing10-Q · Oct 29

Up next

Next earnings call
Feb 23, 2027 Est · unconfirmed · in 14 wks
Q2 2026 earnings call transcript
call held Jul 31, 2026
Play latest call

Latest documents

2026
Oct 29
Quarterly report 10-Q FY2026 Q3, ended Sep 30
Quarterly report for FY2026 Q3

Quaker Chemical Corporation reported third-quarter 2026 net sales of $544.5 million, up 10%, while net income fell to $30.0 million from $30.5 million; adjusted EBITDA rose to $89.8 million from $82.9 million.

Revenue $544.55M ▲ 10.3% Net income $29.98M ▼ 1.6% Diluted EPS $1.73 ▼ 1.1%
Read from the MD&A section
Oct 29
Current report 8-K
Financial results

Quaker Chemical Corporation reported third-quarter 2026 net sales of $544.5 million, up 10% Y/Y, net income of $30.0 million and diluted EPS of $1.73, plus adjusted EBITDA of $89.8 million, up 8% Y/Y.

Oct 22
Current report 8-K Events of Oct 16
Director or officer change, or executive pay

Quaker Chemical Corporation appointed Neil Daniels as Vice President, Chief Accounting Officer effective November 16, 2026, with an annual base salary of $370,000, a 35% target 2027 annual incentive, $110,000 in annual long-term incentive awards, and a $175,000 sign-on bonus.

All documents

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$2.03B
Trailing 12 months
Net income (TTM)
$97.17M
Trailing 12 months
Revenue growth YoY
+10.3%
Year over year
Operating margin
7.6%
Trailing 12 months
P / E (TTM)
27.9
Trailing earnings · reciprocal yield 3.6%
FCF yield
1.5%
TTM · current market cap
Return on invested capital
5.1%
Trailing 12 months
Net cash
−$727.55M
Latest balance sheet
Dividend yield
1.3%
Trailing 12 months
Shares change YoY
-0.4%
Year over year · fewer shares
Price change (1Y)
+14.8%
Trailing year
Short interest
9.6%
Latest settlement · 10.7 days to cover
View all 125 metrics

Quarterly results

Revenue Net income Net loss
▼4.9% $444.09M $14.19M '24 Q4* ▼5.7% $442.91M $12.92M '25 Q1 ▲4.3% $483.40M −$66.58M '25 Q2 ▲6.8% $493.84M $30.47M '25 Q3 ▲5.5% $468.48M $20.70M '25 Q4* ▲8.5% $480.48M $19.67M '26 Q1 ▲10.2% $532.55M $26.84M '26 Q2 LATEST ▲10.3% $544.55M $29.98M '26 Q3

* Q4 derived as the full year minus Q1 to Q3.

AI Brief

Q2 FY26 earnings call · Jul 31, 2026
Q2 FY26

TL;DR. Quaker Houghton posted Q2 2026 net sales up 10% Y/Y to $532.6M with record adjusted EBITDA of $85.2M (+13% Y/Y) on volume growth from new business wins, while management reaffirmed tracking to mid- to high-single-digit full-year EBITDA growth and announced a new $250M share repurchase authorization.

Bullish
  • + Q2 2026 net sales rose 10% Y/Y to $532.6M, with sales volumes up 7% on new business wins across all segments
  • + Adjusted EBITDA hit a record $85.2M, up 13% Y/Y, with adjusted EBITDA margin expanding to 16.0%
  • + Announced new $250M share repurchase authorization and raised quarterly dividend by ~4.3% while repurchasing $24.2M in Q2
Bearish
  • − Americas segment operating earnings declined to $57.2M from $59.0M on higher raw material costs and SG&A expenses
  • − YTD operating cash flow fell to $33.2M from $38.5M on higher working capital outflows
  • − Q2 included $4.1M of business transformation costs and $1.7M of debt modification and extinguishment costs, with management citing heightened volatility and the Strait of Hormuz conflict as headwinds

AI-generated from the earnings call and 8-K · may contain errors · not investment advice

Equibles Rating

blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Buy Momentum Very Strong Sentiment Neutral Fundamentals Fair Quant / Vol Moderate
Market backdrop VIX 19.3 · elevated Equity put/call 0.63
Technical
price trend
Buy
50 / 200-day cross No cross
Price vs 200-day avg +4%
above
Price vs 50-day avg −1%
below
RSI (14) 50
neutral
MACD trend Positive
52-week position 62%
mid-range
Momentum
relative strength
Very Strong
1-month return −1%
trailing
6-month return +6%
trailing
YTD return +13%
this year
Relative strength +6%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $157 › 200d $150 — 50d above 200d
Institutional flow Distributing
286 of 317 funds reported for Sep 30 · net -146.2K sh shares · +32 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
9.58% of shares out · ▼ -4.5% MoM · 10.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
317 holders — near 3-yr high, broad support
Squeeze score 67
elevated · 0–100
Fundamentals
Fair
Revenue growth +3%
Y/Y
Gross margin 36%
contracting
EPS growth −102%
Y/Y
Free cash flow $80.6M
Valuation P/E 27.9
below peers
Buyback $250.0M
authorized
Balance sheet $691.4M
net debt
Quant / Vol
risk profile
Moderate
Volatility 36%
annualized · 1-yr
Max drawdown −36%
past year
ATR 3.3%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Jul 31, 2026
full year 2026
Capital expenditures as a percentage of sales 2.5% – 3%
end of the year
Gross margin 36% – 37%
Previous outlook earlier release · from the Earnings Call filed May 1, 2026

Still-open targets the latest release did not restate under the same label.

Exit this year run rate savings · this year $10M
Sustainable structural cost improvement · next three years $20M – $30M
Cost savings from the closure [of Dortmund, Germany] · 2026 $2M
Annual run rate savings [from Dortmund closure] · beginning in 2027 $5M
Capital expenditures · full-year 2026 2.5% – 3.5%
Gross margin · by the end of the year 36% – 37%
Gross margin · long term / targeted range 36% – 37%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Buy
0 · 4 · 2
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+4% Bullish
Price vs 50-day avg
−1% Neutral
RSI (14)
50 Neutral
MACD trend
Positive Bullish
52-week position
62% Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $157 › 200d $150 — 50d above 200d
Institutional flow Distributing
286 of 317 funds reported for Sep 30 · net -146.2K sh shares · +32 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
9.58% of shares out · ▼ -4.5% MoM · 10.7 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
317 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $115 Now $155 · 62% Range high $181
vs 200-day avg +4% vs 50-day avg -1%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

the company's own KPIs, from written earnings releases and filings
Metric Latest Period YoY
Adjusted EBITDA non-GAAP $157.7M Six Months Ended June 30 —
Adjusted EBITDA margin non-GAAP 15.6% Six Months Ended June 30, 2026 —
EBITDA non-GAAP $73.48M the three months ended June 30, 2026 filing —
GAAP → non-GAAP reconciliation
GAAP Net income (loss) attributable to Quaker Chemical Corporation 26.84M
+25.6M Depreciation and amortization (r)
+9.87M Interest expense
+11.17M Taxes on income before equity in net income of associated companies (s)
= EBITDA 73.48M
Net debt non-GAAP $721M as of June 30, 2026 —
Non-GAAP earnings per diluted share non-GAAP $2.19 Three Months Ended June 30, 2026 filing —
Non-GAAP gross margin non-GAAP 36.1% Six Months Ended June 30, 2026 —
Non-GAAP gross profit non-GAAP $189.2M the three months ended June 30, 2026 filing —
Non-GAAP net income non-GAAP $37.9M Q2 2026 —
GAAP → non-GAAP reconciliation
Adjusted EBITDA 85.17M (non-GAAP)
-25.6M Less: Depreciation and amortization (a)
-9.87M Less: Interest expense
-13.38M Less: Taxes on income before equity in net income of associated companies - adjusted (b)
+1.59M Plus: Acquisition-related depreciation and amortization
= Non-GAAP net income 37.9M
Non-GAAP operating income non-GAAP $55.29M the three months ended June 30, 2026 filing —
GAAP → non-GAAP reconciliation
GAAP Operating income (loss) 40.6M
+0K Acquisition-related step-up inventory amortization (l)
+8.12M Restructuring and related charges, net (a)
+219K Acquisition-related expenses (b)
+0K Gain on inventory and other adjustments (m)
+4.11M Business transformation costs (c)
+0K Impairment charges (o)
+564K Duplicate headquarter lease costs (q)
+1.59M Acquisition-related depreciation and amortization (k)
+86K Other charges (e)
= Non-GAAP operating income 55.29M
Non-GAAP operating margin non-GAAP 9.9% Six Months Ended June 30, 2026 —
Operating Cash Flow $85M Q2 2026 —
Share Repurchases $24M YTD 2026 —
Total Company Volume Trend 7% Q2 2026 —
Trailing twelve months adjusted EBITDA non-GAAP $312.4M twelve-month period ended June 30, 2026 —

Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

Versus peers

Specialty Chemicals — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
KWR
Quaker Chemical Corp
this stock
$2.67B +13.2% +2.7% 27.9 9.6%
LIN
Linde PLC
 $241.51B +23.4% +3.0% 34.9 1.4%
AIQUF
L Air Liquide SA
 $137.11B +14.4% — — 0.0%
ECL
Ecolab Inc.
 $86.74B +17.8% +2.2% 42.1 1.5%
SHW
Sherwin Williams Co
 $84.53B +8.0% +2.1% 32.2 2.5%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
324
% held
90.2%
Reported
286 of 317
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
328
View
Short & Settlement
Short Interest Falling
Shares short
1.6M
Days to cover
10.7d
Change
-77.6K sh
View
Short Volume
Short vol %
76%
As of
Nov 13, 2026
Short Total
View
Fails to Deliver
FTD shares
107
Value
$17.2K
As of
Oct 14, 2026
View
Off-Exchange
Off-exchange %
37.5%
Week of
Oct 5, 2026
Off-exch Lit
View
Financials
Financials
Revenue (FY)
$1.9B
Net income (FY)
$-2.5M
EPS diluted
$-0.14
View
Buybacks
Authorized
$250.0M
View
Filings
SEC Filings
Latest
8-K
Filed
Oct 29, 2026
This year
18

Quaker Chemical Corporation reported third-quarter 2026 net sales of $544.5 million, up 10% Y/Y, net income of $30.0 million and diluted EPS of $1.73, plus adjusted EBITDA of $89.8 million, up 8% Y/Y.

View
Proposed Sales
Value
$1.9M
Shares
13.9K
Filed
Nov 25, 2025
View
Earnings & Events
Webcasts Upcoming
Next webcast
Dec 10, 2026
Last webcast
Oct 30, 2026
View
Investor Relations
Latest news
QUAKER HOUGHTON ANNOUNCES THIRD Q…
Published
Oct 29, 2026
Upcoming events
1
View

Performance

5D 20D 120D MTD YTD
KWR +3.6% -1.0% +6.4% +3.0% +13.2%
SPY +2.6% -1.2% +0.5% -0.2% +10.6%
vs SPY +1.0% +0.2% +5.9% +3.2% +2.6%

Capital returns

Latest dividend
$0.53 / share · ex Oct 16, 2026
Raised 4.3%
Paid (TTM)
$2.054 / share · 4 payouts
Dividend yield (TTM, derived)
1.32%
Full dividend history
Buyback program · as of May 13, 2026
Authorized
$250.00M
Spent (derived)
—
Remaining
—

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 81362 CUSIP 747316107 13F (30d) 260 filings 238 filers Visit website Investor relations